Cephalexin is a semi-synthetic first-generation oral cephalosporin, which has weak antibacterial efficacy, but is acid-resistant and is well absorbed by oral administration.
This report contains market size and forecasts of Cephalexin Capsules in global, including the following market information:
Global Cephalexin Capsules Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cephalexin Capsules Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cephalexin Capsules companies in 2021 (%)
The global Cephalexin Capsules market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
125mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cephalexin Capsules include GSK, Abbot, Sun Pharma, Teva, Cipla, Cadila Healthcare, Dr Reddy's Laboratories, Aurobindo Pharma and Innova Captab, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cephalexin Capsules manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cephalexin Capsules Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cephalexin Capsules Market Segment Percentages, by Type, 2021 (%)
125mg
250mg
500mg
Global Cephalexin Capsules Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cephalexin Capsules Market Segment Percentages, by Application, 2021 (%)
Respiratory Tract Infection
Skin and Soft Tissue Infections
Urinary Tract Infection
Other
Global Cephalexin Capsules Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cephalexin Capsules Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cephalexin Capsules revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cephalexin Capsules revenues share in global market, 2021 (%)
Key companies Cephalexin Capsules sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cephalexin Capsules sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Abbot
Sun Pharma
Teva
Cipla
Cadila Healthcare
Dr Reddy's Laboratories
Aurobindo Pharma
Innova Captab
Alkem Laboratories
Ascend Laboratories
Lupin
Orchid Pharma
Karalex Pharma
Shanghai Hengshan Pharmaceutical
Jilin Huinan Sanhe Pharmaceutical
Jilin Daojun Pharmaceutical